Table 1.
Risk factors of invasive fungal diseases in Senegal, prevalence, and incidence of the principal underlying diseases.9–12.
| Risk factors of fungal diseases | Prevalence | Incidence |
|---|---|---|
| HIV | 0.5% (0.5–1.5) | 1300 per 1000 population (1000–1600) |
| TB | 0.08% (2019) | 140 cases/100.000 inhabitants from 2000 to 2016, 122 in 2017 and 118 in 2018 |
| Asthma* | 10% | 3% (children) and 6% (adults) |
| Diabetes | 5.1% | 771,579 people living with diabetes |
| Leukemia | 1.86%‡ | 145 cases (1.3%) in 2020 |
| Non-Hodgkin lymphoma | 3.76‡ | 312 cases (2.8%) in 2020 |
*
Non-published data from the Albert Royer University Hospital for Children in Dakar presented during an academic session of the National Academy of Technical Sciences of Senegal (ANSTS).
‡
Five-year prevalence (all ages): proportion per 100,000.